Löhr H F, Krug S, Herr W, Weyer S, Schlaak J, Wölfel T, Gerken G, Meyer zum Büschenfelde K H
Department of Internal Medicine, Johannes-Gutenberg-University, Mainz, Germany.
Liver. 1998 Dec;18(6):405-13. doi: 10.1111/j.1600-0676.1998.tb00825.x.
AIMS/BACKGROUND: CD4+ T-helper cell (Th) responses to hepatitis B virus (HBV) core antigen (HBc) are increased during exacerbations in acute and chronic hepatitis B (AHB, CHB) and might influence the induction of CD8+ cytotoxic T lymphocytes (CTL) that are important for viral clearance.
HBc-specific proliferative responses and cytokine release of blood mononuclear cells (PBMC) were studied in patients with AHB or CHB, as well as responders and non-responders to interferon-alpha treatment (IFN-R, IFN-NR), by [3H]-thymidine-uptake, enzyme-linked immunosorbent assay (ELISA) and Elispot assay and were compared to peptide HBc18 27-specific CTL precursor frequencies among CD8+ T cells derived from HLA-A2+ patients.
HBc-specific proliferative PBMC responses and Th frequencies were significantly increased in AHB patients compared with untreated CHB patients. PBMC derived from IFN-R showed stronger cellular responses than IFN-NR. Stimulated PBMC from all patient groups secreted significantly more IFN-gamma than IL-4 indicating Th1/Th0 cell responses. Furthermore, in AHB and IFN-R patients, high peptide HBc18-27-specific CTL precursor frequencies closely correlated with strong HBc-specific Th responses, whereas in untreated CHB and IFN-NR patients lower CTL frequencies were observed without correlation to Th activities.
HBV core-specific Th-cell responses appeared to support efficient CTL induction in patients with viral clearance, whereas in chronic HBV carriers quantitatively insufficient Th and CTL responses were observed. This observation could be important for future therapeutic strategies.
目的/背景:在急性和慢性乙型肝炎(AHB、CHB)病情加重期间,CD4 +辅助性T细胞(Th)对乙型肝炎病毒(HBV)核心抗原(HBc)的反应增强,这可能会影响对病毒清除至关重要的CD8 +细胞毒性T淋巴细胞(CTL)的诱导。
通过[3H] - 胸腺嘧啶核苷摄取、酶联免疫吸附测定(ELISA)和酶联免疫斑点测定(Elispot assay),研究了AHB或CHB患者以及α干扰素治疗的应答者和无应答者(IFN-R、IFN-NR)中HBc特异性增殖反应和血液单核细胞(PBMC)的细胞因子释放,并与来自HLA-A2 +患者的CD8 + T细胞中肽HBc18 - 27特异性CTL前体频率进行比较。
与未经治疗的CHB患者相比,AHB患者中HBc特异性增殖PBMC反应和Th频率显著增加。来自IFN-R的PBMC显示出比IFN-NR更强的细胞反应。所有患者组刺激后的PBMC分泌的IFN-γ明显多于IL-4,表明存在Th1/Th0细胞反应。此外,在AHB和IFN-R患者中,高肽HBc18 - 27特异性CTL前体频率与强烈的HBc特异性Th反应密切相关,而在未经治疗的CHB和IFN-NR患者中,观察到较低的CTL频率,且与Th活性无关。
HBV核心特异性Th细胞反应似乎支持病毒清除患者中有效的CTL诱导,而在慢性HBV携带者中观察到Th和CTL反应在数量上不足。这一观察结果可能对未来的治疗策略很重要。